Diagnosis of RCC is generally based on morphological and immunohistochemical properties of tissue samples, though chromosome 3p alteration and especially VHL gene mutational status are the molecular pathology features recognized as strongest support for clear cell RCC diagnosis, and evolving profiles of markers exist for the other subtypes as well [102]. The gene discussed is VHL; the disease is renal cell adenocarcinoma.